nfr-logonfr-logo
PROSJEKTBANKEN
Switch to English
Se statistikken
Se prosjektene

0 antall prosjekter

Dato fra ny til gammel

H20-HEALTH-Health, demographic change and wellbeing

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

Tildelt: kr 20,2 mill.

Prosjektperiode: 2019-2024

Sted: Trøndelag - Trööndelage

H20-HEALTH-Health, demographic change and wellbeing

Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

ConcePTION partners have united around a shared vision that we have a societal obligation to radically and rapidly reduce uncertainty about the safety of medication use in pregnancy and lactation. What do we deliver? ConcePTION aims to create a paradigm shift in how we study medication safety...

Tildelt: kr 7,0 mill.

Prosjektperiode: 2019-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)

ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)

Tildelt: kr 8,1 mill.

Prosjektperiode: 2019-2023

Sted: Akershus

H20-HEALTH-Health, demographic change and wellbeing

MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response

Decompensation of liver cirrhosis and progression towards acute-on-chronic liver failure (ACLF) causes 1.2 million deaths/year. Microbiome is causally involved in cirrhosis progression and is for drugs the first interaction point with the patients. Drugs can alter the microbiome leading to unwant...

Tildelt: kr 1,4 mill.

Prosjektperiode: 2019-2025

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Scaling up the WHO-PEN package for diabetes and hypertension in Swaziland: a nation-wide cluster-randomised evaluation of three strategies in Swaziland (WHO-PEN@Scale)

Swaziland has a very high prevalence of both diabetes and hypertension, with the majority of those affected being undiagnosed. Like many other countries in sub-Saharan Africa (SSA), however, Swaziland provides care for diabetes and hypertension only through physician-led teams in hospitals. The c...

Tildelt: kr 2,1 mill.

Prosjektperiode: 2019-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients

NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients

Tildelt: kr 1,0 mill.

Prosjektperiode: 2019-2024

Sted: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

European Joint Programme on Rare Diseases

As recognized by the Council Recommendation 2009/C 151/02, rare diseases (RD) are a prime example of a research area that can strongly profit from coordination on a European and international scale. RD research should be improved to overcome fragmentation, leading to efficacious use of data and r...

Tildelt: Skjult

Prosjektperiode: 2019-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Integrating and decentralising diabetes and hypertension services in Africa

We will integrate and scale up services for diabetes and hypertension in clinics in Tanzania and Uganda, either as standalone or integrated with HIV-infection. This builds on pilot studies that the partners are conducting, funded by UK NIHR, on the prevention and management of HIV, diabetes and ...

Tildelt: kr 0,35 mill.

Prosjektperiode: 2019-2022

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Living well, dying well. A research programme to support living until the end

Every year around 4 million people die in the EU as a result of chronic disease and illness. Many will die in pain or distress, die alone, and die without appropriate health or social care. How we care for the dying is perhaps the most pressing personal, social and public health issue of the 21st...

Tildelt: kr 3,3 mill.

Prosjektperiode: 2019-2022

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY

ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY

Tildelt: kr 3,5 mill.

Prosjektperiode: 2019-2022

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

SYNergies for Cohorts in Health: integrating the ROle of all Stakeholders

SYNergies for Cohorts in Health: integrating the ROle of all Stakeholders

Tildelt: kr 2,2 mill.

Prosjektperiode: 2019-2022

Sted: Trøndelag - Trööndelage

H20-HEALTH-Health, demographic change and wellbeing

Vaccines and Infectious Diseases in the Ageing PopuLation

Vaccines and Infectious Diseases in the Ageing PopuLation

Tildelt: kr 3,3 mill.

Prosjektperiode: 2019-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and Ebola

Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and Ebola

Tildelt: kr 354,7 mill.

Prosjektperiode: 2019-2022

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Metabolic effects of Endocrine Disrupting Chemicals: novel testing METhods and adverse outcome pathways

Metabolic effects of Endocrine Disrupting Chemicals: novel testing METhods and adverse outcome pathways

Tildelt: kr 2,7 mill.

Prosjektperiode: 2019-2023

Sted: Trøndelag - Trööndelage

H20-HEALTH-Health, demographic change and wellbeing

Advanced Secure Cloud Encrypted Platform for Internationally Orchestrated Solutions in Healthcare

Advanced Secure Cloud Encrypted Platform for Internationally Orchestrated Solutions in Healthcare

Tildelt: kr 6,3 mill.

Prosjektperiode: 2018-2022

Sted: Troms - Romsa - Tromssa

H20-HEALTH-Health, demographic change and wellbeing

Bringing a prophylactic Ebola vaccine to licensure

Bringing a prophylactic Ebola vaccine to licensure

Tildelt: Skjult

Prosjektperiode: 2018-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

conect4children (COllaborative Network for European Clinical Trials For Children)

conect4children (COllaborative Network for European Clinical Trials For Children)

Tildelt: kr 6,5 mill.

Prosjektperiode: 2018-2024

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Building social and emotional skills to BOOST mental health resilience in children and young people in Europe

Building social and emotional skills to BOOST mental health resilience in children and young people in Europe

Tildelt: kr 22,2 mill.

Prosjektperiode: 2018-2021

Sted: Trøndelag - Trööndelage og 3 andre

H20-HEALTH-Health, demographic change and wellbeing

How to best meet the needs of people with dementia with severe behavioural disturbances. Toward a respectful and cost-effective model

The RECAGE project will tackle one of the most challenging problem arising during the clinical course of dementia: the so-called Behavioural and Psychological Symptoms of Dementia (BPSD). The current state-of-the-art of the treatment of these symptoms is still unsatisfactory and there are many un...

Tildelt: kr 1,2 mill.

Prosjektperiode: 2018-2022

Sted: Innlandet

H20-HEALTH-Health, demographic change and wellbeing

Efficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trial

TENSION (efficacy and safety of ThrombEctomy iN Stroke with extended leSION and extended time window: a randomized, controlled trial) strives at providing innovative treatment to patients with severe stroke to reduce the individual and societal burden of death and dependency from stroke. To this ...

Tildelt: kr 2,4 mill.

Prosjektperiode: 2018-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Systems Medicine of Metabolic-Signaling Networks: A New Concept for Breast Cancer Patient Stratification

Systems Medicine of Metabolic-Signaling Networks: A New Concept for Breast Cancer Patient Stratification

Tildelt: kr 9,8 mill.

Prosjektperiode: 2018-2022

Sted: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative

Bipolar disorder (BD) is a prevalent mental disorder and a leading cause of suicide. Lithium (Li) is the key mood stabilizer for prevention of BD relapse and suicide. Whilst many cases become asymptomatic with Li treatment, the majority show sub-optimal response. Identifying biomarkers for predic...

Tildelt: kr 1,7 mill.

Prosjektperiode: 2018-2022

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Universal Preventive Resilience Intervention Globally implemented in schools to improve and promote mental Health for Teenagers

Universal Preventive Resilience Intervention Globally implemented in schools to improve and promote mental Health for Teenagers

Tildelt: kr 2,9 mill.

Prosjektperiode: 2018-2021

Sted: Trøndelag - Trööndelage

H20-HEALTH-Health, demographic change and wellbeing

Testing the value of a novel strategic approach and its cost efficacy to improve the poor outcomes in Cardiogenic Shock

Testing the value of a novel strategic approach and its cost efficacy to improve the poor outcomes in Cardiogenic Shock

Tildelt: kr 2,8 mill.

Prosjektperiode: 2018-2022

Sted: Troms - Romsa - Tromssa

H20-HEALTH-Health, demographic change and wellbeing

A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide (OligoG) for cystic fibrosis

The objective of the current proposal is to advance the orphan drug OligoG CF-5/20 (OligoG) through a pivotal phase IIb clinical trial, to enable a new and improved therapeutic approach for the orphan disease cystic fibrosis by 2024. The study drug is an alginate oligosaccharide derived from sea...

Tildelt: kr 53,4 mill.

Prosjektperiode: 2018-2022

Sted: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Preventive school-based interventions to promote the mental well-being of refugee and migrant adolescents

Today, European societies face the challenge of promoting the integration of growing numbers of refugee and migrant adolescents. Supporting the mental well-being of these young newcomers is herein pivotal, with recent scholarly work emphasizing the preventive role of schools in promoting mental w...

Tildelt: kr 5,8 mill.

Prosjektperiode: 2018-2022

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Personalised Prognostic Models to Improve Well-being and Return to Work After Neck and Low Back Pain

Neck and low back pain (NLBP) are leading causes for years lived with disability in Europe and worldwide. About 70% of all adults experience NLBP at some point in their lives, and both conditions are among the top ten in terms of overall disease burden expressed as disability adjusted life years....

Tildelt: kr 6,1 mill.

Prosjektperiode: 2018-2021

Sted: Trøndelag - Trööndelage

H20-HEALTH-Health, demographic change and wellbeing

Personalised maxillofacial bone regeneration

Personalised maxillofacial bone regeneration

Tildelt: kr 9,1 mill.

Prosjektperiode: 2018-2021

Sted: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

ERA-Net Cofund in Personalised Medicine

ERA PerMed will serve as a funding vehicle of topics identified in the Strategic Research and Innovation Agenda (SRIA) in Personalised Medicine and the Action Plan of ICPerMed. ERA PerMed will coordinate R&I efforts of the participating partners (funding agencies from EU, associate countries to...

Tildelt: kr 2,1 mill.

Prosjektperiode: 2017-2023

Sted: Akershus

H20-HEALTH-Health, demographic change and wellbeing

Soraprazan - a new regenerative therapy for Stargardt's disease

Soraprazan - a new regenerative therapy for Stargardt's disease

Tildelt: kr 14,6 mill.

Prosjektperiode: 2017-2021

Sted: Oslo

12345